Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a lenticule implant clear cloudy corneas from viral infection?

NCT ID NCT05123014

Disease control Sponsor: Eye Hospital Pristina Kosovo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests a two-part approach for people with corneal scarring caused by adenoviral keratitis. Surgeons first remove the scarred tissue using a laser technique called SMILE, then implant a fresh, clear corneal lenticule of the same size into the pocket. Patients also receive autologous serum eye drops to support healing. The goal is to see whether this can restore corneal transparency and improve vision without the scarring coming back.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a fresh corneal lenticule (stromal tissue) implanted in the eye plus autologous serum eye drops
What this could lead to
If it works, this approach could offer a new way to restore corneal transparency and improve vision in people with stubborn scarring from adenoviral keratitis.
What could go wrong
This is a small, early-stage trial with 45 participants. The procedure involves surgery and carries risks such as infection, graft rejection, or no lasting improvement in vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

45 people

The number who actually took part.

Started

Feb 2018

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

24 to 43 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * low transparency of cornea * low visual acuity * recurrence keratitis Exclusion Criteria: * active anterior segment pathology * previous corneal or anterior segment surgery * any infection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenoviral keratoconjunctivitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epidemic keratoconjunctivitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adenoviral keratoconjunctivitis

Contacts and locations

Locations

  • Eye Hospital Pristina

    Pristina, 10000, Kosovo